KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $573.7 million.

  • Edwards Lifesciences' Cash from Operations rose 6307.56% to $573.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 2609.13%. This contributed to the annual value of $542.3 million for FY2024, which is 3946.19% down from last year.
  • Latest data reveals that Edwards Lifesciences reported Cash from Operations of $573.7 million as of Q3 2025, which was up 6307.56% from $290.2 million recorded in Q2 2025.
  • Edwards Lifesciences' Cash from Operations' 5-year high stood at $573.7 million during Q3 2025, with a 5-year trough of -$127.5 million in Q4 2024.
  • Its 5-year average for Cash from Operations is $291.2 million, with a median of $309.9 million in 2022.
  • Data for Edwards Lifesciences' Cash from Operations shows a peak YoY increase of 100565.48% (in 2024) and a maximum YoY decrease of 19333.82% (in 2024) over the last 5 years.
  • Edwards Lifesciences' Cash from Operations (Quarter) stood at $373.6 million in 2021, then decreased by 24.3% to $282.8 million in 2022, then plummeted by 51.7% to $136.6 million in 2023, then plummeted by 193.34% to -$127.5 million in 2024, then skyrocketed by 549.96% to $573.7 million in 2025.
  • Its Cash from Operations was $573.7 million in Q3 2025, compared to $290.2 million in Q2 2025 and $280.4 million in Q1 2025.